FDA vs. EU: Decoding Medical Device Risk and Classification Pathways

This episode demystifies the critical process of medical device classification in the US and EU. Learn the principles behind risk-based classification and how it directly impacts your path to market, from documentation to regulatory scrutiny. Key Questions: • What are the three medical device risk classes in the United States? • How does the EU's four-class system (I, IIa, IIb, III) differ from the FDA's? • Why is a device's classification the single most important factor for its regulatory strategy? • What is a 510(k) and when is it required? • What is a Premarket Approval (PMA) application? • How does risk level determine the need for a Notified Body in Europe? • What is a CE Mark and how is it related to device class? • What are the consequences of misclassifying your medical device? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.